Phibro Animal Health (PAHC) Tops Q4 EPS by 8c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts PAHC Hot Sheet
Join SI Premium – FREE
Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.41, $0.08 better than the analyst estimate of $0.33. Revenue for the quarter came in at $273.2 million versus the consensus estimate of $260.49 million.
GUIDANCE:
Phibro Animal Health sees FY2025 EPS of $1.22-$1.37, versus the consensus of $1.24. Phibro Animal Health sees FY2025 revenue of $1.04-1.09 billion, versus the consensus of $1.029 billion.
For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Airbnb (ABNB) call put ratio 1 call to 1.3 puts into quarter results
- Avnet (AVT) Tops Q1 EPS by 97c ; Offers Guidance
- Flutter Entertainment plc (FLUT) Misses Q3 EPS by 525c; lowers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
